The severe shortage of human organs for transplantation is the driving force behind xenotransplant research. Nonhuman primates, particularly baboons, are potential sources of organs and tissues. Human cytomegalovirus (HCMV) is the most common donor-associated infection after allotransplantation. Baboon cytomegalovirus (BCMV) is endemic in baboon populations and therefore is a potential cause of donor-associated disease after xenotransplantation. Accordingly, the ability for BCMV to grow in human cells was determined and a sensitive method to distinguish BCMV from HCMV was developed. Human fibroblasts were permissive for BCMV, isolates exhibited cytopathology characteristic of HCMV, and herpesvirus-like virions were observed by electron microscopy. BCMV and HCMV could be distinguished by restriction fragment length polymorphism patterns and by polymerase chain reaction with primers targeting the BCMV major immediateearly gene promoter. These methods can be used to evaluate BCMV pathogenicity in laboratory and clinical xenotransplant trials.
Allotransplantation has become an effective treatment for endConsequently, recent experiments with xenotransplantation have been done using baboon livers [3, 4] and baboon bone stage organ disorders involving the kidney, liver, heart, or lung. The escalating demand for transplantation coupled with the inmarrow [9] . Increasing public debate has focused on the safety of these procedures. However, investigation into the infectious creasing shortage of human organ donors is the driving force behind xenotransplantation, using animal tissue for human transrisk associated with the use of baboon organs or bone marrow has been limited [10 -14] . A major obstacle has been the lack plantation. In addition, the apparent resistance of some animals to specific human pathogens (e.g., hepatitis B virus [1] and of available techniques to distinguish nonhuman primate viruses from analogous human viruses. human immunodeficiency virus type 1 [2] ) has led to an increasing number of experimental protocols in which animal organs Human cytomegalovirus (HCMV) remains the most common and important donor-associated infection after allotransor bone marrow are transplanted into humans [3] [4] [5] .
Currently, the animals considered the best potential sources plantation [15 -19] . The greatest risk factor for development of disease due to HCMV, in this population, is transplantation of organs and tissues for xenotransplantation into humans are the baboon and pig [6 -8] . While immunologic barriers leading of an organ from a seropositive donor to a seronegative recipient [15 -20] . Even patients who are HCMV-seropositive before to rejection of the animal organs are substantial with either animal, they appear to be more easily overcome when transtransplant are at risk for reactivation or reinfection with other strains [15] . Consequently, the analogous baboon cytomegaloplantation is undertaken between more closely related species [8] . Organs from nonhuman primates, which are phylogenetivirus (BCMV) may be a serious pathogen after xenotransplantation. Evaluation of adult baboon sera measuring antibody cally closer to humans, are rejected less vigorously than organs from animals, such as the pig, that are more distantly related.
directed against HCMV found a high prevalence of seropositivity [10 -12] . Accordingly, serology will not discriminate between infection with BCMV and HCMV. Methods to distinguish BCMV from HCMV are necessary to evaluate the 16 years. Viral cultures were obtained from healthy animals as part mM EDTA, 0.5% SDS, 1 mg/mL proteinase K), and DNA was extracted with phenol-chloroform and precipitated in 2. 25] . Briefly, clinical specimens were seeded onto 3.7-mL vials containing MRC-5 human lung fibroblast cells on by the dideoxy chain-termination method [29] . A portion of this sequence representing the BCMV MIE gene promoter-enhancer coverslips (BioWhittaker). After inoculation, the vials were centrifuged at 2000 g for 45 min at 36ЊC. Vials were incubated for 18 region was used to design oligonucleotide primers for the specific amplification of a 173-bp DNA product [30] [31] [32] . Comparative h at 36ЊC. Coverslips were fixed with acetone and stained with a monoclonal antibody directed against the HCMV p72 major analysis of sequences between BCMV and HCMV was done using , and CMV pp65 antigenemia. HCMV antigenemia studies (directed against HCMV pp65 antigen) were done directly on buffy coat 2.5 U of Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) in a 100-mL reaction volume. Amplifications were done in a specimens as described [26, 27] . In brief, white blood cells were obtained by dextran sedimentation of heparinized whole blood thermal cycler (PHC3; Techne, Princeton, NJ). Cycling conditions consisted of initial denaturation at 95ЊC for 5 min, a subsequent from individual animals and diluted to 1 1 10 6 cells/mL. Three cytospin preparations were prepared for each specimen, with 2 1 denaturation at 95ЊC for 1 min, annealing at 52ЊC for 30 s, and extension at 72ЊC for 2 min for 40 cycles. Fifteen microliters of 10 5 cells (0.2 mL)/slide. Slides were formalin-fixed, permeabilized, and stained with an anti-pp65 monoclonal antibody (1C3 clone; each PCR reaction underwent electrophoresis in a 1.5% agarose gel. Molecular weight markers were included for DNA fragment Argene Biosoft, Varilhes, France). Slides were then incubated with FITC-labeled goat anti-mouse F(ab) 2 time for evidence of CPE in primary culture of the HFF or containing membrane envelope, as well as nuclear dense core particles characteristic of the herpesvirus family, can be seen. MRC5 cells was 12 days (range, 6 -27). Specimens growing BCMV were collected from swabs of the oropharynx (13/40), Anti-HCMV monoclonal antibody staining. Monoclonal antibodies directed against the HCMV p72 MIE antigen recogmouth lesions (3/3), conjunctiva (1/1), urine (1/2), and buffy coats (2/24). Tissues from autopsies were inoculated from 7 nized some BCMV on rapid spin cultures. One (2%) of 48 specimens inoculated onto rapid spin cultures demonstrated animals; BCMV was isolated from lungs (2/4), lymph nodes (1/3), kidney (1/3), and spleen (1/4) but not from liver (0/3) positive staining, with a pattern that was indistinguishable from that of control HCMV isolates. In addition, cytopathology was or stomach ulceration (0/1).
Electron microscopy of specimens. An electron micrograph positive on conventional culture of this specimen. Four BCMV isolates, obtained from throat, urine, and lung cultures, gave of virus isolates obtained from the oropharynx of a baboon and grown on HFF cells is shown in figure 1B . The cytoplasm of inconsistent results when stained with a p72 monoclonal antibody. Fifteen buffy coat specimens obtained from baboons a human fibroblast is shown, with numerous lysosomes containing budded herpes-like particles. Some complete virions were negative on direct staining with monoclonal antibody / 9d3b$$de30 10-29-97 18:02:44 jinfal UC: J Infect specific for HCMV matrix protein pp65; only 2 of the 15 were determined to be unique to BCMV when compared with homologous regions of the HCMV genome ( figure 3 ). Sespecimens developed CPE by conventional culture.
RFLP. RFLP profiles of the DNA extracted from a laboraquences of the MIE promoter regions of BCMV, rhesus monkey CMV, and Colburn strain CMV were also compared [28, tory strain of HCMV, chimpanzee CMV, and BCMV are shown in figure 2. Notable differences are seen between the fragment 36]. Amplification with the BCMV-specific primers produced a 173-bp product from 2 isolates of BCMV. No product was profiles after SalI digestion of BCMV compared with the CMV isolates from human and chimpanzee. A second isolate of detected after amplification of DNA extracted from CMV from other primates, including human, chimpanzee, and African BCMV from a different baboon was compared with the first isolate of BCMV, with only minimal differences in restriction green monkeys, Colburn and SA6 ( figure 4A ). Southern blot hybridization is shown in figure 4B , done on the PCR products fragment profiles (data not shown).
CMV PCR. PCR-based detection was done using primers from figure 4A using 32 P-labeled BCMV MIE gene as a probe. Hybridization occurred only with amplified DNA from the 2 derived from the MIE gene promoter-enhancer region, which BCMV isolates. To determine whether these PCR primers would amplify DNA from BCMV isolates of other baboons, DNA was separately extracted from 7 isolates obtained from 5 different animals; 3 isolates were from a single animal. The 173-bp product was seen with all of these specimens but not from the laboratory strains of HCMV (AD169, Towne) or from a low-passage primary HCMV isolate from a clinical specimen ( figure 5 ). In addition, these primers did not amplify DNA extracted from 3 other primary HCMV clinical isolates or from other human herpesviruses, including herpes simplex virus types 1 and 2 and varicella-zoster virus (data not shown). PCRbased assays using previously described HCMV-specific primers [37] failed to support amplification of the isolates of BCMV, whereas amplification was found with DNA extracted from control isolates of HCMV (data not shown).
Discussion
Animal viruses, which can be latent in organs or the accompanying hematopoietic cells, may have potential to be transmitted to humans through xenotransplantation. To address issues of whether BCMV can be transmitted to humans, investigations such as the current study are necessary to first develop methods that can detect BCMV and differentiate it from HCMV. Earlier studies have indicated as high as 98% seropositivity to BCMV in mature animals [10] , making it unlikely that seronegative animals will be readily available for xenotransplant procedures. Serologic studies show cross-reactivity between BCMV and HCMV [10 -12] . Additionally, serologic markers, even if unique, may be inadequate in severely immunocompromised xenotransplant recipients, who may have limited abilities to mount an immunologic response. The current investigation indicates that BCMV and HCMV cannot be reliably distinguished morphologically when grown on standard HFF cultures nor when observed with electron microscopy. Inconsistent results were also found when using immunofluorescent detection methods for HCMV antigens, making these methods of detec- substantial immunosuppression. Acyclovir prophylaxis was This study demonstrates that BCMV and HCMV can be readily distinguished on the basis of DNA differences through used in the immunosuppressed animals from whom cultures were obtained and thereby may have decreased the risk of RFLP analysis and PCR. The RFLP patterns suggest that HCMV and chimpanzee CMV are more similar to each other BCMV shedding. than either are to BCMV; sequence data from several loci [39] . Human-to-human transmission of B virus has been documented from an infected person to the spouse [39] . Thus, support this (data not shown). Recognizable differences between BCMV and HCMV are critical to monitor transmission this simian a-herpesvirus is adaptable to the human species. Pseudorabies, the a-herpesvirus of swine, also leads to fatal of BCMV for xenotransplant procedures. Similar to our strategy, Hilliard et al.
[38] used a PCR-based technique to distindisease when species lines are broached, as happens with experimental or accidental transmission to dogs, sheep, or guish BCMV from HCMV. Their report evaluated BCMV isolated from urine samples of baboons and from the parotid gland cows [40] . Anecdotal evidence exists for nonfatal pseudorabies infection in humans [41] . The ability of a benign herpesof 1 baboon. Interestingly, CPE developed only after 7 passages on Vero cells. This compares to a median of 12 days on HFF virus to cause more severe disease in another species and to be transmissible within the new species creates public health cells in the current study, which is similar to growth characteristics of HCMV [23] . The faster growth in our study is likely concerns for infection and secondary transmission with a baboon (or swine) herpesvirus after xenotransplantation [14] . due to the cells chosen for virus isolation.
The similar growth characteristics of BCMV and HCMV Less is known about transmission of b-herpesviruses, such as CMV, across species barriers into humans. However, nonin human tissue culture noted in this study, along with the ability to passage virus, demonstrates replication competence human primate (African green monkey) CMV has been implicated as the cause of neurologic disease in 2 humans [42 -in vitro and suggests the potential for in vivo infectivity. Recognition of transmission of herpesviruses from animals to 45]. The CMV strain, Colburn, isolated from the brain biopsy of an encephalopathic young boy was found to have substanhumans is uncommon. Typically, these viruses are considered species-restricted. In a few instances, however, herpesviruses tial homology with a simian CMV (strain GR2757) by reassociation kinetic analyses, suggesting cross-species infection have been found to cross the species barrier. Transmission of the a-herpesvirus, herpes simiae (B virus), of macaques to [36, 42] . In a separate case, Martin and colleagues [44, 45] reported that a virus compatible with African green monkeyhumans is a dramatic example of a herpesvirus that is characteristically benign in its normal host but causes disease in a like CMV was repeatedly isolated from the peripheral blood of a woman with chronic fatigue syndrome. Experimental new species [39] . This virus is analogous to human herpes simplex virus and causes self-limited recurrent oral or genital inoculation of Colburn strain CMV showed that it was also able to establish primary and persistent infection in marmosets lesions in its natural host. Accidental introduction into a human host through a monkey bite or scratch leads to an as-(a third primate species) [46] . These reports highlight the possibility of transmission of animal viruses to humans cending myelitis that is almost always fatal when untreated JID 1997;176 (December) CMV disease in CMV-seronegative recipients of allografts from CMVthrough xenotransplantation. It is therefore critical to develop seropositive donors following liver transplantation. J Infect Dis 1996; reproducible laboratory methods, as described here, for the 173:1072 -6. detection of animal viruses within the human environment.
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